Quick CV Dropoff
Send us your CV
Demand for quality and regulatory talent is high across the pharma industry. Consequently, it is becoming increasingly difficult for smaller companies to compete in the jobs market. In this article, we examine the primary causes of this competitive environment and how you can combat it.
The use of technologies in life sciences is shifting the speed at which new devices, medications, and treatments are being developed. As pharma companies expand their reach into areas such as stem cell research, gene therapy, and mobile medical devices, the need for effective quality and regulatory talent will increase.
Companies will need to consider security around patient data, R&D programs, corporate assets, and the accelerated FDA timelines on regulatory submissions for new drugs and clinical trials.
The pharma sector is experiencing huge growth around the world. According to research from Precedence Research, we can expect the pharmaceutical manufacturing to grow at a CAGR of 12.8% from 2021 to 2030 – expanding from $358 billion to almost $1.2 trillion by the end of the decade. Reasons for this growth include:
COVID-19 has demonstrated how quickly the industry is now able to develop, manufacture, and distribute new drugs. Quality and RA professionals are key to enabling the pace of growth to continue.
While demand for RA professionals is increasing, supply is not. There simply aren’t enough graduates coming through the system. One of the reasons for this may be cost. PhD programs in science and research are supported by government grants, subsidies, and other measures – programs in regulatory science are not. In addition, employers don’t reimburse fees.
Students are often unaware of the range of careers available in quality and regulatory roles, with the consequence that graduate training programs are difficult to market to students. It has also been found that job titles are described as ‘confusing’.
Often, there is a lack of in-house training for existing employees, meaning that the senior roles vacated by retiring baby-boomers are those that need to be filled.
Those graduates who do come to the job market are often not employed because they lack the experience to take on management roles – the type of jobs that are mostly being hired for. They are overqualified for entry-level jobs, and under-experienced for more senior roles.
As demand for regulatory affairs professionals increases, the salaries they expect are increasing, too. This is partly because companies are using higher salaries to attract new hires, but also because big pharma are increasing the salaries of existing staff to retain them. This spiraling of salaries is making it hard for many smaller companies to recruit the talent they need.
These factors have combined to create an immediate problem in many pharma companies. They are reliant on experienced, skilled people in senior roles, but have no suitable talent coming through.
As the importance of quality and regulatory affairs continues to grow, the skills gap is widening, and the talent pool is contracting. How can you combat this and hire the people your company needs? Strategies include:
Of course, all these measures take time to put into place and bear fruit, and they require considerable investment. The results, too, are not certain. But without such measures, it is likely that the spiraling of salaries in a discipline that is short of talent will continue.
For immediate outcomes, you should consider the range of hiring options available to you. This includes:
To learn more about how Catalyst Life Sciences can help with each of these solutions, contact us today.